Global Med Technologies(R), Inc. and Stanford University Medical Center Sign Contract for Transfusion Management System
October 08 2004 - 10:30AM
PR Newswire (US)
Global Med Technologies(R), Inc. and Stanford University Medical
Center Sign Contract for Transfusion Management System Stanford
Selects SafeTrace Tx(R) Advanced Transfusion Management System
DENVER, Oct. 8 /PRNewswire-FirstCall/ -- Wyndgate Technologies(R),
a division of Global Med Technologies(R), Inc. (OTC:GLOB) (BULLETIN
BOARD: GLOB) ("Global Med"), announced the signing of an agreement
for its SafeTrace Tx(R)* advanced transfusion management system
with Stanford University Medical Center. This contract will make
Stanford the largest SafeTrace Tx client on the West coast. Terms
were not disclosed. (Logo:
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO) Susie
Lu, VP of Pathology and Laboratory Medicine at Stanford Hospital
and Clinics and Lucile Packard Children's Hospital, said, "Our
clinical staff selected Wyndgate's SafeTrace Tx transfusion
management system for its comprehensive safety features, as well as
its integration capabilities, which will facilitate the automation
of many of the paper processes currently in use in our transfusion
service." Ms. Lu added, "Wyndgate, with its expertise in the blood
bank industry, has successfully developed software to manage the
complexities of both the transfusion service and the donor
facility. As Stanford Medical School Blood Center currently uses
Wyndgate's SafeTrace Donor Management System, the Stanford
Transfusion Service Laboratory will benefit from the enhanced
efficiencies that come with having linked software systems." Thomas
F. Marcinek, President and COO of Global Med Technologies, Inc.,
stated, "We are very pleased to announce this major agreement with
Stanford University Medical Center, a prestigious academic research
facility, recognized internationally for its excellence in
healthcare." Mr. Marcinek added, "Our partnership with Stanford
highlights Wyndgate's commitment to quality and safety by
automating the management of the blood transfusion cycle from
collection to transfusion, safely and efficiently." About Stanford
University Medical Center Stanford University Medical Center is
known worldwide for the advanced patient care provided by its
staff, for the treatment of rare, complex disorders such as cardiac
care, cancer treatment, neurology, neurosurgery and organ
transplants. Stanford University Medical Center and its physicians
consistently rank among the top in the nation in surveys by
consumers and health care professionals and in July, 2002, was
named to the Honor Roll of America's Best Hospitals by U.S. News
& World Report. For more information about Stanford University
Medical Center and its three institutions (Stanford Hospital and
Clinics, Lucile Packard Children's Hospital and Stanford University
School of Medicine), visit its website at
http://www.stanfordhospital.com/. About Global Med Technologies,
Inc. Global Med Technologies, Inc. is an international e-Health,
medical information technology company, providing information
management software products and services to the healthcare
industry. Its Wyndgate Technologies division is a leading supplier
of information management systems to U.S. and international blood
centers and hospital transfusion centers. Current clients of
Wyndgate's products and services manage more than 3 million units
of blood, or over 22% of the U.S. blood supply, each year.
Wyndgate's products are also being implemented in Canada, the
Caribbean and sub-Saharan Africa. Together, the SafeTrace Tx
advanced transfusion management system and the SafeTrace donor
management system provide Vein-to-Vein(R) tracking from donor
collection to patient transfusion. For more information about
Global Med's products and services, please call 800-WYNDGATE or
visit http://www.globalmedtech.com/, http://www.peoplemed.com/ and
http://www.wyndgate.com/. This news release may include statements
that constitute forward-looking statements, usually containing the
words "believe," "estimate," "project," "expects" or similar
expressions. These statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements inherently involve risks and
uncertainties that could cause actual results to differ materially
from the forward-looking statements. By making these
forward-looking statements, the Company undertakes no obligation to
update these statements for revisions or changes after the date of
this news release. *Patent Pending
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies(R),
Inc. CONTACT: Press, Patti Larson, Senior Director of Marketing
Development, +1-916-404-8492, ; or Investors, Tom Marcinek,
President and COO, +1-916-404-8413, , all of Wyndgate Technologies
Web site: http://www.stanfordhospital.com/ Web site:
http://www.peoplemed.com/ http://www.wyndgate.com/
http://www.globalmedtech.com/
Copyright